Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Avantis International Equity ETF (AVDE)

Avantis International Equity ETF (AVDE)
66.05 x 7 70.28 x 2
Post-market by (Cboe BZX)
66.27 +0.72 (+1.10%) 04/17/25 [NYSE Arca]
66.05 x 7 70.28 x 2
Post-market 66.27 unch (unch) 20:00 ET
News & Headlines for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish

Genmab receives royalties on the worldwide net sales of Darzalex, both the intravenous and subcutaneous products, under J&J's exclusive worldwide license to develop, manufacture, and commercialize daratumumab....

GMAB : 20.04 (+2.51%)
AVDE : 66.27 (+1.10%)
FBT : 152.24 (-0.09%)
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved

The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517.

APIE : 29.28 (+1.24%)
NVO : 58.08 (-7.63%)
AVDE : 66.27 (+1.10%)
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish

The company said that its earnings consist of income from dividends and the share repurchase programmes of Novo Group companies Novo Nordisk A/S and Novonesis A/S, as well as returns from its investment...

APIE : 29.28 (+1.24%)
NVO : 58.08 (-7.63%)
AVDE : 66.27 (+1.10%)
Novo Nordisk Stock Slips After BofA, Morgan Stanley Slash Price Targets – But Retail Goes Contrarian

Bank of America analysts said Novo Nordisk might miss first-quarter estimates. According to TheFly, they expect the company to lower its full-year sales guidance from 16%-24% at constant exchange rates...

NVO : 58.08 (-7.63%)
AVDE : 66.27 (+1.10%)
Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves

Novo Nordisk will obtain exclusive worldwide rights to develop, manufacture, and commercialize the drug UBT251, while United Biotechnology will, however, retain the rights to the drug in mainland China,...

APIE : 29.28 (+1.24%)
NVO : 58.08 (-7.63%)
AVDE : 66.27 (+1.10%)
Sony Stock Surges After Q3 Earnings Beat, Raised Outlook: Retail’s Not Convinced

For full-year 2024, Sony expects revenue to be about JPY 13.2 trillion ($876 billion), 4% higher than its previous outlook.

SONY : 24.01 (+2.78%)
APIE : 29.28 (+1.24%)
AVDE : 66.27 (+1.10%)
Toyota Downgraded After Second Straight Profit Drop, But Stock Climbs As Annual Outlook Improves: Retail Stays Optimistic

Toyota also announced plans to establish a wholly owned company in Shanghai to develop and produce Lexus BEVs and batteries.

FVD : 42.94 (+0.77%)
APIE : 29.28 (+1.24%)
AVDE : 66.27 (+1.10%)
TM : 176.38 (+0.73%)
BP, Kosmos Energy Stocks In Spotlight After First Gas Flow From GTA Phase 1 Project: Retail Turns Bullish

Once commissioned, GTA Phase 1 is expected to produce around 2.3 million tonnes of liquefied natural gas (LNG) annually. 

DFIV : 38.63 (+0.94%)
AVDE : 66.27 (+1.10%)
BP : 28.32 (+2.39%)
KOS : 1.7900 (+7.83%)
Toyota Stock Catches Retail's Eye After Report Of Auto Giant's Aim To Double Equity Returns

The news boosted Toyota’s shares by nearly 6% in Tokyo trading earlier in the day.

FVD : 42.94 (+0.77%)
APIE : 29.28 (+1.24%)
AVDE : 66.27 (+1.10%)
TM : 176.38 (+0.73%)
Sony Stock Jumps Pre-Market As Profit Booms Nearly 70%: Retail Buzz Builds

Despite selling only 3.8 million PlayStation 5 units this quarter — down from 4.9 million a year ago — Sony raised its annual profit forecast.

SONY : 24.01 (+2.78%)
APIE : 29.28 (+1.24%)
AVDE : 66.27 (+1.10%)
AVIV : 56.37 (+1.06%)

Barchart Exclusives

Goldman Sachs Just Upgraded This Blue-Chip Stock. Should You Buy It Now?
With a strong pipeline, this pharmaceutical powerhouse is positioning itself as a dominant force in the future of medicine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro